Redhill Biopharma Ltd Quick Ratio (RDHL) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Redhill Biopharma Ltd   (NASDAQ: RDHL)

Redhill Biopharma Ltd 's Quick Ratio

RDHL's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the fourth quarter 2025, Quick Ratio deteriorated to 0.21 below Redhill Biopharma Ltd 's average Quick Ratio.

Within Major Pharmaceutical Preparations industry 465 other companies have achieved higher Quick Ratio than Redhill Biopharma Ltd in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from 3487 to 4079.

Explain Quick Ratio?
How much Cash & cash equivalents RDHL´s has?
What are RDHL´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RDHL Quick Ratio (Dec 31 2025)
Q4		 0
Q3		 0
Q2		 0
Q1		 (Dec 31 2024)
Q4
Y / Y Current Liabilities Change -17.83 % -13.51 % -16.9 % -13.51 % 3.87 %
Y / Y Cash & cash equivalent Change -13.99 % -13.99 % -60.62 % -13.99 % -17.09 %
Quick Ratio MRQ 0.21 0.21 0.14 0.21 0.2
RDHL's Total Ranking # 4079 # 3487 # # #
Seq. Current Liabilities Change 0 % -4.16 % 4.34 % -17.83 % 5.26 %
Seq. Cash & cash equivalent Change 0 % 38.56 % -27.83 % -13.99 % 0 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 466
Healthcare Sector # 912
Overall Market # 4079


Quick Ratio Statistics
High Average Low
896.43 27.08 0.1
(Dec 31 2016)   (Dec 31 2022)




Financial Statements
Redhill Biopharma Ltd 's Current Liabilities $ 19 Millions Visit RDHL's Balance sheet
Redhill Biopharma Ltd 's Cash & cash equivalent $ 4 Millions Visit RDHL's Balance sheet
Source of RDHL's Sales Visit RDHL's Sales by Geography


Cumulative Redhill Biopharma Ltd 's Quick Ratio

RDHL's Quick Ratio for the trailling 12 Months

RDHL Quick Ratio

 (Dec 31 2025)
12 Months		 0
12 Months		 0
12 Months		 0
12 Months		 (Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth -15.5 % -10.11 % -3.66 % 3.05 % 10.33 %
Y / Y Cash & cash equivalent TTM Growth -30.05 % -30.14 % -30.22 % -9.97 % -10.86 %
Quick Ratio TTM 0.19 0.19 0.19 0.23 0.23
Total Ranking TTM # 3826 # 3758 # # #
Seq. Current Liabilities TTM Growth -5.09 % -3.54 % -4.58 % -3.26 % 0.96 %
Seq. Cash & cash equivalent TTM Growth -4.19 % -4.02 % -21.54 % -3.06 % -4.31 %

Quick ratio ranking by company, industry and sector >> Back to RDHL Financial Strength Comparisons >> Go to Compare RDHL Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in RDHL's Current Liabilities to $19.22 millions, cumulative Quick Ratio to 0.19 below the RDHL average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 441 other companies have achieved higher Quick Ratio than Redhill Biopharma Ltd . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from 3758 to 3826.

Explain Quick Ratio?
How much Cash & cash equivalents RDHL´s has?
What are RDHL´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 442
Healthcare Sector # 905
Within the Market # 3826


trailing twelve months Quick Ratio Statistics
High Average Low
2.76 0.68 0.1
0   (Dec 31 2022)




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Esperion Therapeutics Inc   0.56 $ 167.852  Millions$ 300.810  Millions
Biofrontera Inc   0.54 $ 6.392  Millions$ 11.895  Millions
Bioxcel Therapeutics Inc   0.53 $ 28.415  Millions$ 53.926  Millions
Apollomics Inc   0.52 $ 3.276  Millions$ 6.326  Millions
Merck and Co Inc   0.51 $ 14,565.000  Millions$ 28,327.000  Millions
Jupiter Neurosciences Inc   0.51 $ 3.789  Millions$ 7.375  Millions
Tuhura Biosciences Inc   0.51 $ 3.620  Millions$ 7.048  Millions
Immunic Inc   0.51 $ 15.483  Millions$ 30.618  Millions
Indivior Pharmaceuticals Inc   0.50 $ 212.000  Millions$ 424.000  Millions
Phibro Animal Health Corporation  0.50 $ 77.039  Millions$ 154.451  Millions
Assertio Holdings inc   0.49 $ 63.405  Millions$ 128.107  Millions
Aytu Biopharma Inc  0.49 $ 30.952  Millions$ 63.064  Millions
Heron Therapeutics Inc   0.49 $ 46.631  Millions$ 96.098  Millions
Clene Inc   0.48 $ 5.189  Millions$ 10.776  Millions
Akari Therapeutics Plc  0.47 $ 5.203  Millions$ 11.019  Millions
Elanco Animal Health Incorporated  0.46 $ 545.000  Millions$ 1,181.000  Millions
Quantum Biopharma Ltd   0.46 $ 1.905  Millions$ 4.182  Millions
Bristol myers Squibb Company  0.44 $ 10,673.000  Millions$ 24,396.000  Millions
Grifols Sa  0.42 $ 943.040  Millions$ 2,261.280  Millions
Novartis Ag  0.41 $ 11,640.000  Millions$ 28,072.000  Millions
Eli Lilly And Company  0.41 $ 7,268.000  Millions$ 17,846.000  Millions
Aeon Biopharma inc   0.40 $ 3.006  Millions$ 7.467  Millions
Tiziana Life Sciences Ltd  0.36 $ 4.010  Millions$ 11.209  Millions
Ac Immune Sa  0.36 $ 33.764  Millions$ 94.693  Millions
Amneal Pharmaceuticals Inc   0.35 $ 310.871  Millions$ 881.633  Millions
Lftd Partners Inc   0.35 $ 1.817  Millions$ 5.162  Millions
Genmab A  0.34 $ 269.485  Millions$ 785.827  Millions
Aditxt Inc   0.34 $ 3.358  Millions$ 9.902  Millions
Medicure Inc   0.33 $ 2.938  Millions$ 8.896  Millions
Protagenic Therapeutics Inc new  0.32 $ 2.213  Millions$ 6.824  Millions

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.